Companies/BIMI International Medical Inc.

Company profile

BIMI International Medical Inc.

OTC: BIMI · Healthcare · Medical - Pharmaceuticals

PublicHQ New York, CIK 0001213660Reports USD

#611 of 1,402 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ —GM —SS 52

v0.1 · 5/100 weight · pillars only

↑ 3-yr revenue growth, disclosure history · ↓ market scale, growth stability

Methodology →

Revenue TTM

$11.8M

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$22.4M

Employees

296

Market cap

$1.2k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$11.8M$11.8M2022

Net income-$22.4M-$22.4M2022

Operating income-$15.3M-$15.3M2022

Total assets$35.7M$35.7M2022

Liabilities$30.5M$30.5M2022

Equity$4.0M$4.0M2022

Revenue trend

FY2014 – FY2022 · USD

$10.0M

FY14

$6.7M

FY15

$6.0M

FY16

$8.5M

FY17

$158.0k

FY19

$12.8M

FY21

$27.1M

FY21

$11.8M

FY22

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

BIMI International Medical Inc. booked $11.8M in FY2022 revenue, contracting 56% year over year — slower than 84% of Healthcare companies we track, at a -189.3% net margin.

Peers · Healthcare

PhaseRx, Inc.——BG Medicine, Inc.——Modern Technology Corp.——Imagin Medical Inc.——

Key facts

CEOTiewei Song

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersNew York, null

ExchangeOTC: BIMI

Employees296

IPO date2006-10-18

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.